cAMP‐ and Ca2+/calmodulin‐dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes
- 14 December 2010
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 162 (2) , 544-556
Abstract
BACKGROUND AND PURPOSE Urocortin 2 is beneficial in heart failure, but the underlying cellular mechanisms are not completely understood. Here we have characterized the functional effects of urocortin 2 on mouse cardiomyocytes and elucidated the underlying signalling pathways and mechanisms.EXPERIMENTAL APPROACH Mouse ventricular myocytes were field‐stimulated at 0.5 Hz at room temperature. Fractional shortening and [Ca2+]i transients were measured by an edge detection and epifluorescence system respectively. Western blots were carried out on myocyte extracts with antibodies against total phospholamban (PLN) and PLN phosphorylated at serine‐16.KEY RESULTS Urocortin 2 elicited time‐ and concentration‐dependent positive inotropic and lusitropic effects (EC50: 19 nM) that were abolished by antisauvagine‐30 (10 nM, n= 6), a specific antagonist of corticotrophin releasing factor (CRF) CRF2 receptors. Urocortin 2 (100 nM) increased the amplitude and decreased the time constant of decay of the underlying [Ca2+]i transients. Urocortin 2 also increased PLN phosphorylation at serine‐16. H89 (2 µM) or KT5720 (1 µM), two inhibitors of protein kinase A (PKA), as well as KN93 (1 µM), an inhibitor of Ca2+/calmodulin‐dependent protein kinase II (CaMKII), suppressed the urocortin 2 effects on shortening and [Ca2+]i transients. In addition, urocortin 2 also elicited arrhythmogenic events consisting of extra cell shortenings and extra [Ca2+]i increases in diastole. Urocortin 2‐induced arrhythmogenic events were significantly reduced in cells pretreated with KT5720 or KN93.CONCLUSIONS AND IMPLICATIONS Urocortin 2 enhanced contractility in mouse ventricular myocytes via activation of CRF2 receptors in a cAMP/PKA‐ and Ca2+/CaMKII‐dependent manner. This enhancement was accompanied by Ca2+‐dependent arrhythmogenic effects mediated by PKA and CaMKII.Keywords
This publication has 50 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 4th editionBritish Journal of Pharmacology, 2009
- Urocortin induces positive inotropic effect in rat heartCardiovascular Research, 2009
- Angiotensin II and myosin light-chain phosphorylation contribute to the stretch-induced slow force response in human atrial myocardiumCardiovascular Research, 2008
- Urocortin 2 infusion in human heart failureEuropean Heart Journal, 2007
- Effect of urocortin 1 infusion in humans with stable congestive cardiac failureClinical Science, 2005
- Cardioprotection mediated by urocortin is dependent upon PKCε activationThe FASEB Journal, 2005
- Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Activation of Protein Kinase B/Akt by Urocortin is Essential for its Ability to Protect Cardiac Cells Against Hypoxia/Reoxygenation-induced Cell DeathJournal of Molecular and Cellular Cardiology, 2002
- Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brainNeuron, 1993
- Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptorsFEBS Letters, 1993